Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Sotera Health (SHC) EBIT (2020 - 2026)

Sotera Health has reported EBIT over the past 6 years, most recently at $108.4 million for Q4 2025.

  • For Q4 2025, EBIT rose 24.4% year-over-year to $108.4 million; the TTM value through Dec 2025 reached $392.8 million, up 31.97%, while the annual FY2025 figure was $392.8 million, 31.97% up from the prior year.
  • EBIT for Q4 2025 was $108.4 million at Sotera Health, down from $114.3 million in the prior quarter.
  • Over five years, EBIT peaked at $114.3 million in Q3 2025 and troughed at $33.4 million in Q1 2023.
  • A 5-year average of $73.6 million and a median of $71.9 million in 2022 define the central range for EBIT.
  • On a YoY basis, EBIT climbed as much as 72.89% in 2023 and fell as far as 37.62% in 2023.
  • Year by year, EBIT stood at $66.4 million in 2021, then fell by 9.42% to $60.2 million in 2022, then soared by 72.89% to $104.0 million in 2023, then fell by 16.23% to $87.1 million in 2024, then increased by 24.4% to $108.4 million in 2025.
  • Business Quant data shows EBIT for SHC at $108.4 million in Q4 2025, $114.3 million in Q3 2025, and $97.7 million in Q2 2025.